Physician
Internal Medicine
Dr. Robert Lonigro IV, MD
Robert Lonigro is an expert in the field of Internal Medicine. He went to medical school at Rutgers Robert Wood Johnson Medical School. Rutgers Robert Wood Johnson Medical School has a rank of 74 in research and a 67 in primary care Robert Lonigro is also published. He has 40 publications published. The lastest publication: "Expression of thyroid transcription factor 1 gene can be regulated at the transcriptional and posttranscriptional levels.' Robert Lonigro IV is registered with Medicare and accepts Medicare payments.
Publications
- The miR-124-Prolyl Hydroxylase P4HA1-MMP1 axis plays a critical role in prostate cancer progression.
- Primary Urethral Clear-Cell Adenocarcinoma: Comprehensive Analysis by Surgical Pathology, Cytopathology, and Next-Generation Sequencing.
- Activating ESR1 mutations in hormone-resistant metastatic breast cancer.
- Identification of Targetable FGFR Gene Fusions in Diverse Cancers.
- Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing.
- Characterization of the EZH2-MMSET histone methyltransferase regulatory axis in cancer.
- Nestin is a neuroepithelial target gene of thyroid transcription factor-1, a homeoprotein required for forebrain organogenesis.
- TTF-1 gene expression in human lung tumours.
- A thyroid-specific nuclear protein essential for tissue-specific expression of the thyroglobulin promoter.
- The tissue-specific expression of the thyroglobulin gene requires interaction between thyroid-specific and ubiquitous factors.
- Definition of the DNA-binding specificity of TTF-1 homeodomain by chromatographic selection of binding sequences.
- Thyroid specific gene expression.
- Thyroid-specific gene expression is differentially influenced by intracellular glutathione level in FRTL-5 cells.
- The thyroid transcription factor-1 gene is a candidate target for regulation by Hox proteins.
- A network of specific minor-groove contacts is a common characteristic of paired-domain-DNA interactions.
- Expression of thyroid transcription factor 1 gene can be regulated at the transcriptional and posttranscriptional levels.
- Molecular events in the differentiation of the thyroid gland.
- The neuronal repellent SLIT2 is a target for repression by EZH2 in prostate cancer.
- Personalized oncology through integrative high-throughput sequencing: a pilot study.
- Detection of somatic copy number alterations in cancer using targeted exome capture sequencing.
- Functionally recurrent rearrangements of the MAST kinase and Notch gene families in breast cancer.
- Coordinated regulation of polycomb group complexes through microRNAs in cancer.
- Urine TMPRSS2:ERG fusion transcript stratifies prostate cancer risk in men with elevated serum PSA.
- TMPRSS2-ERG-mediated feed-forward regulation of wild-type ERG in human prostate cancers.
- Mechanistic rationale for inhibition of poly(ADP-ribose) polymerase in ETS gene fusion-positive prostate cancer.
- Characterization of bone metastases from rapid autopsies of prostate cancer patients.
- Re: Florian Jentzmik, Carsten Stephan, Kurt Miller, et al. Sarcosine in urine after digital rectal examination fails as a marker in prostate cancer detection and ident...
- An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression.
- Chimeric transcript discovery by paired-end transcriptome sequencing.
- AGTR1 overexpression defines a subset of breast cancer and confers sensitivity to losartan, an AGTR1 antagonist.
- Fluorescence in situ hybridization study shows association of PTEN deletion with ERG rearrangement during prostate cancer progression.
- Development of a multiplex quantitative PCR signature to predict progression in non-muscle-invasive bladder cancer.
- Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression.
- Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer.
- A fluorescence in situ hybridization screen for E26 transformation-specific aberrations: identification of DDX5-ETV4 fusion protein in prostate cancer.
- CXCL5 promotes prostate cancer progression.
- A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer.
- Course of FEV(1) after onset of bronchiolitis obliterans syndrome in lung transplant recipients.
- Surgical patient outcomes after the increased use of bilateral lung transplantation.
Schools
University of Medicine And Dentistry of New Jersey Robert Wood Johnson Medical School
Hartford Hospital
UCLA St Mary Med Center
Doctors Specialties
- Internal Medicine
Accepted Insurances
- Blue Card PPO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- GHI PPO
Education
-
Hartford Hospital -
Rutgers Robert Wood Johnson Medical School
Helpful Reviews
Similar Doctors
|
Dr. Stephanie L. Limbert, MD |
|
|
Dr. Rafay S. Mehdi, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tharwat A. Hanna, MD
This Doctor is OpenDoctor Recommended.
|